CCA
EXAS

Cadent Capital Advisors’s Exact Sciences EXAS Stock Holding History

Cadent Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,685
Closed -$209K – 134
2021
Q2 		$209K Hold
1,685
– – 0.09% 134
2021
Q1 		$222K Buy
+1,685
New +$231K 0.1% 118

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cadent Capital Advisors's EXAS Position: Q3 2021 in Review

Cadent Capital Advisors sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 1,685 shares — an estimated $209K sold.

Cadent Capital Advisors first reported a position in EXAS in Q1 2021 and held it in 2 quarters. The position peaked at $222K in Q1 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Cadent Capital Advisors reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Cadent Capital Advisors sold 1,685 Exact Sciences shares in Q3 2021, an estimated $209K.
  • Cadent Capital Advisors first reported a position in Exact Sciences in Q1 2021 and held it in 2 quarters.
  • Cadent Capital Advisors's Exact Sciences position peaked at $222K in Q1 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Cadent Capital Advisors's 13F filing for Q3 2021, filed 25 Oct 2021.